NCT07351240Active, not recruiting
The Acupuncture Treatment Effect in Patients With Schizophrenia
The Quality of Life of Acupuncture Treatment Effect in Patients With Schizophrenia
Source: ClinicalTrials.gov · Last updated 3 Nov 2026
Brief summary (registry, in English)
Among various psychiatric disorders, this study focuses specifically on patients with schizophrenia. The aim of this study is to evaluate the therapeutic effects of acupuncture on antipsychotic medication-related side effects and psychiatric symptoms in patients with schizophrenia. This is a single-blind randomized study. Participants will be randomly assigned to one of two groups: Neiguan and Shenmen. Both the Neiguan and Shenmen groups will receive acupuncture treatment twice weekly, with each session lasting 30 minutes, for a total of four consecutive weeks. Assessments will be conducted prior to acupuncture intervention and after each acupuncture session. All assessment data will be collected and analyzed using statistical methods including descriptive statistics, chi-square tests, and t-tests. Generalized Estimating Equations (GEE-I) and multiple linear regression analyses will be applied to examine differences in psychological health, quality of life, and happiness before and after acupuncture intervention. It is anticipated that acupuncture will reduce antipsychotic-related side effects, improve psychiatric symptoms in patients with schizophrenia, and subsequently enhance patients' quality of life and happiness.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- First submitted
- 12 Jan 2026
- Start date
- 16 Dec 2025
- Primary completion date
- 31 Jul 2026
- Lead sponsor
- Calo Psychiatric Center
- Diseases
- Schizophrenia
- NCT number
- NCT07351240
What you commit to
- Study type: Interventional
- Planned participants: 100
- From 16 Dec 2025 to the primary completion date, 31 Jul 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Severe medical illnesses (e.g., cancer, chronic liver disease, renal failure)
- History of stroke or other causes of hemiplegia
- Severe dermatological disease or limb edema
- Severe cognitive impairment
- Severe hepatic, renal, cardiac, pulmonary, or hematological disease
- Major infectious diseases (e.g., HIV infection)
Other
- High risk of violence or suicide
- Alcohol or substance abuse or dependence
- Pregnancy or breastfeeding
- Refusal to provide informed consent
Who the study is looking for
- Diagnosis of schizophrenia according to DSM-5 criteria for at least six months
- Personal and Social Performance Scale score ≥ 50
Age in the registry: 20 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Calo Psychiatric Center Coordinator of this site? Confirm its status | Pingtung City | Taiwan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.